PR Vademécum Chile 2026
PR Vademécum Chile 2026
Download on App Store

This page is not an official page of the app or its developer, but an independent editorial publication created for informational and commentary purposes. Unless expressly stated otherwise, neither the app nor its developer is affiliated with, endorsed by, sponsored by, authorized by, or otherwise officially connected with MWM, Apple, Google Play, the app publisher, or the app's developer, and nothing on this page implies that the app was developed using MWM's services. Any trademarks, logos, screenshots, and other content remain the property of their respective owners.

Logo of PR Vademécum Chile 2026
Download on App Store

PR Vademécum Chile 2026

Ensure clinical safety with instant access to updated pharmacological data, drug interactions, and therapeutic indexes for the Chilean pharmaceutical market.

Key Figures

Downloads

6K+

User Rating

2.9/5

Total Ratings

0

Publisher

Clyna S.A.

Category

Medical

Locales

2

Latest Version

7.1.3

Size

80.3 MB

First Released

Feb 6, 2019
Features

Empower Your Clinical Decisions with Precision

The definitive pharmaceutical guide for Chilean medications, specifically curated for healthcare providers, researchers, and pharmacists needing reliable international data and safety insights.

Advanced Interaction Analysis

Ensure patient safety with a comprehensive database of active principles and their potential drug-to-drug interactions to prevent adverse clinical outcomes.

Precise Substance Identification

Instantly translate Chilean brand names into generic active ingredients, bridging the gap between US medical protocols and international prescriptions.

The following screenshots and description are sourced directly from the app's official store listing and are the property of the app developer.

App Store

Screenshots

PR Vademécum Chile 2026 - Medical information page for the drug Degraler in the PR Vademecum Chile 2026 application

Medical information page for the drug Degraler in the PR Vademecum Chile 2026 application

PR Vademécum Chile 2026 - PR Vademecum Chile app interface showing a search for Degraler in the product index

PR Vademecum Chile app interface showing a search for Degraler in the product index

PR Vademécum Chile 2026 - Mobile app interface of PR Vademecum Chile showing a list of medical products from Laboratorios Bago

Mobile app interface of PR Vademecum Chile showing a list of medical products from Laboratorios Bago

Description

Información actualizada de medicamentos y drogas de prescripción médica. PR Vademécum contiene información actualizada de medicamentos y drogas de prescripción médica comercializadas en Chile. P.R. Vademécum fue desarrollado a partir de fuentes confiables, como las empresas elaboradoras y la bibliografía médico-farmacológica disponible en la actualidad. La aplicación permite acceder por los siguientes índices: - Productos Contiene el texto del prospecto de los productos que se comercializan en Chile. - Laboratorios Contiene el listado de laboratorios y los productos que comercializa cada uno. - Patologías Contiene el listado de patologías y los productos indicados para cada una - Interacciones Contiene el listado de principios activos y las interacciones de cada uno. - Índice Farmacológico Contiene el texto de la acción de los principios activos. - Índice Terapéutico Contiene el listado de las acciones terapéuticas y los productos indicados para cada una. - I.S.P.R. Índice de Sustancias y Productos Relacionados Contiene el listado de los principios y los productos que contienen cada uno. Exención de responsabilidad: PR Vademécum no debe considerarse un medio autónomo y suficiente para recetar aquellos medicamentos o sustancias sobre los que informa; sus destinatarios deben utilizarlo como un complemento de su indelegable responsabilidad profesional, teniendo en cuenta que el lector posee los conocimientos necesarios para interpretar la información aportada por este aplicativo.

Download

Download on App Store

This page is not an official page of the app or its developer, but an independent editorial publication created for informational and commentary purposes. Unless expressly stated otherwise, neither the app nor its developer is affiliated with, endorsed by, sponsored by, authorized by, or otherwise officially connected with MWM, Apple, Google Play, the app publisher, or the app's developer, and nothing on this page implies that the app was developed using MWM's services. Any trademarks, logos, screenshots, and other content remain the property of their respective owners.